Karolinska Institutet, Department of Medicine, Huddinge, Lipid Laboratory, Stockholm, Sweden.
J Clin Endocrinol Metab. 2010 May;95(5):2451-7. doi: 10.1210/jc.2009-2049. Epub 2010 Mar 12.
Fibroblast growth factors (FGFs) regulate the development of white adipose tissue (WAT). However, the secretion and cellular origin of individual FGFs in WAT as well as the influence of obesity are unknown.
Our objective was to map FGFs in human sc WAT, the cellular source, and association with obesity.
Secretion, mRNA, and circulatory levels of FGFs in human abdominal sc WAT from nonobese and obese donors were examined by microarray, real-time quantitative PCR, and ELISA. The activity of FGFs in cultured human adipocytes was determined by phosphorylation assays.
Expression of five FGFs (FGF1, FGF2, FGF7, FGF9, and FGF18) and FGF homologous factor (FHF2) was identified in WAT. Only FGF1 was released in a time-dependent manner from sc WAT, and fat cells were the major source of FGF1 secretion. FGF1 expression increased and FGF2 decreased during adipocyte differentiation. Furthermore, FGF1 was not secreted into the circulation. Although FGF1 levels were 2-fold increased in obesity, they were unaltered by weight reduction. Only FGF1 and FGF2 induced a marked concentration-dependent phosphorylation of p44/42 in cultured human adipocytes.
Of the investigated FGFs, only FGF1 is secreted from sc WAT and predominantly so from the adipocyte fraction. The activity in adipocyte cultures and lack of secretion into the circulation suggest that FGF1 acts as an auto- or paracrine factor. FGF1 levels are increased in obesity but unaffected by weight reduction, suggesting a primary defect in obese individuals. In conclusion, FGF1 may play a superior role among the FGFs in sc WAT and obesity development.
成纤维细胞生长因子(FGFs)调节白色脂肪组织(WAT)的发育。然而,WAT 中单个 FGF 的分泌和细胞来源以及肥胖的影响尚不清楚。
我们的目的是绘制人类皮下 WAT 中的 FGF 图谱,确定其细胞来源,并研究其与肥胖的关系。
通过微阵列、实时定量 PCR 和 ELISA 检测非肥胖和肥胖供体的人腹部皮下 WAT 中的 FGF 分泌、mRNA 和循环水平。通过磷酸化测定法确定 FGF 在培养的人脂肪细胞中的活性。
在 WAT 中鉴定出五种 FGF(FGF1、FGF2、FGF7、FGF9 和 FGF18)和 FGF 同源因子(FHF2)的表达。只有 FGF1 以时间依赖性方式从皮下 WAT 中释放出来,脂肪细胞是 FGF1 分泌的主要来源。在脂肪细胞分化过程中,FGF1 的表达增加,而 FGF2 的表达减少。此外,FGF1 并未分泌到循环中。尽管肥胖症患者的 FGF1 水平增加了 2 倍,但体重减轻并未改变其水平。只有 FGF1 和 FGF2 可诱导培养的人脂肪细胞中 p44/42 的显著浓度依赖性磷酸化。
在所研究的 FGF 中,只有 FGF1 从皮下 WAT 中分泌,主要来自脂肪细胞部分。在脂肪细胞培养物中的活性以及缺乏向循环中的分泌表明 FGF1 作为自分泌或旁分泌因子发挥作用。肥胖症患者的 FGF1 水平增加,但体重减轻后不受影响,这表明肥胖个体存在主要缺陷。总之,FGF1 可能在皮下 WAT 和肥胖症发展中发挥优于其他 FGF 的作用。